Impact Assessment Fees for Pharmaceutical Services (IA 5098)

This initiative introduced in 2008, through Directions to NHS Primary Care Trusts (PCTs), a charging regime for applicants applying to provide NHS pharmaceutical services as a contribution towards the costs the NHS incurs in dealing with such applications. This IA updates the previous 2008 impact assessment to take account of a review of that original initiative in 2009 and changes now being introduced to the main NHS (Pharmaceutical Services) Regulations from summer 2012 which govern entry to the NHS market.

DH 5098 Fees NHS pharmaceutical services (PDF 121K)

Equality Analysis Fees NHS pharmaceutical services (PDF 84K)

In Impact assessments, Transparency | Tagged

Comments are closed.